Evidence map›Paper›PMID 42114100›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

Michael W T Tanck, Yanushi D Wijeyeratne, Julien Barc, Alison Muir, Takeshi Aiba, J Martijn Bos, Christian Veltmann, Joseph Galvin, Lia Crotti, Taisuke Ishikawa and 27 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Michael W T TanckAmsterdam UMC, University of Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, Meibergdreef 9, Amsterdam, Netherlands.ORCID 0000-0001-9828-4459
Yanushi D WijeyeratneCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.ORCID 0000-0003-0656-5769
Julien BarcDepartment of Medical Genetics, Nantes Université, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.ORCID 0000-0003-4106-5946
Alison MuirBelfast Health and Social Care Trust, Belfast, UK.
Takeshi AibaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0003-1779-7282
J Martijn BosDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3635-2003
Christian VeltmannCenter of Electrophysiology Bremen, Bremen, Germany.ORCID 0000-0001-7587-1124
Joseph GalvinMater Misericordiae University Hospital, Dublin, Ireland.ORCID 0000-0002-3617-8738
Lia CrottiIstituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.ORCID 0000-0001-8739-6527
Taisuke IshikawaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0001-8195-4700
Seiko OhnoDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0003-1209-8896
Stephen P PageLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Isabelle DenjoyAP-HP Nord, Hôpital Bichat, Cardiology Department and Reference Center for Hereditary Arrhythmic Diseases, Paris Cité University, INSERM U1166, Paris, France.ORCID 0000-0002-1786-9461
David J TesterDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.
Martina MuggenthalerCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.
Kazuhiro TakahashiKizawa Memorial Hospital, Gifu, Japan.ORCID 0000-0002-1964-9219
Hariharan RajuCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.ORCID 0000-0003-0000-7520
Jean Baptiste GourraudNantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.ORCID 0000-0002-6961-2131
Richard RedonNantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.ORCID 0000-0001-7751-2280
Jean-Jacques SchottNantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.ORCID 0000-0002-9578-9475
Carla Haglund-TurnquistDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.
Matteo PedrazziniIstituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.ORCID 0000-0002-0675-4845
Chiara AlberioIstituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.ORCID 0000-0002-4727-0994
Federica DagradiIstituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.ORCID 0000-0002-1090-3292
Michael PapadakisCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.ORCID 0000-0003-0616-2353
Sanjay SharmaCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.ORCID 0000-0002-3630-6138
Edward PetzerDarent Valley Hospital, Dartford and Gravesham NHS Trust, Dartford, UK.ORCID 0009-0009-8600-0813
Dan M RodenVanderbilt University School of Medicine, Nashville, USA.ORCID 0000-0002-6302-0389
Minoru HorieShiga University of Medical Science, Shiga, Japan.ORCID 0000-0002-9029-2339
Peter J SchwartzIstituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.ORCID 0000-0003-0367-1048
Naomasa MakitaDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-1807-672X
Martin M BorggrefeDepartment of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Mannheim, Germany.ORCID 0000-0002-3206-934X
Michael J AckermanDepartments of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.
Wataru ShimizuDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0001-9941-8973
Pascal P McKeownBelfast Health and Social Care Trust, Belfast, UK.
Vincent ProbstNantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.ORCID 0000-0002-5492-8619
Elijah R BehrCardiovascular and Genomics Research Institute, School of Health and Medical Sciences, City St George's University of London, London SW17 0RE, UK.ORCID 0000-0002-8731-2853

Funding

ANR European Joint ProgrammeANR JCJCBritish Heart FoundationClinical Research Hospital ProgramFédération Française de CardiologieFrench Ministry of HealthHigher Education Funding Council for EnglandJames Lancaster Memorial FundLEARN R21006NNLEARN RPV21014NNALQTS-NEXTMayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death ProgramMcColl's RG LtdMedical Research CouncilNational Institute of Health Research
6 · The paper itself

Abstract

aimsSCN5A-E1784K (c.5350G>A) is the most common variant associated with the long QT (LQTS) and Brugada syndromes (BrS). It can manifest variably as LQTS, BrS, and/or conduction disorders. This presents a challenge for risk stratification. We aimed to describe clinical and ECG characteristics and identify risk markers that associate with arrhythmic events. METHODS AND

resultsWe undertook a retrospective observational multicentre study of a large cohort of 231 subjects with SCN5A-E1784K from Europe, USA, and Japan. Comprehensive demographic and clinical data, including initial presentation ECG and follow-up, were collected. 'Lethal events' were defined as sudden death, non-fatal cardiac arrest, and documented sustained VT or VF. 'Cardiac events' were defined as arrhythmic syncope plus any lethal events. Clinical characteristics and ECG parameters corrected for age were investigated for association with lethal and/or cardiac events. Fourteen (6%) subjects experienced a lethal event and 45 (19%) a cardiac event. PR interval and QRS duration were associated with lethal and cardiac events. In multivariable models, both PR interval and QRS duration were associated with lethal events, but only QRS duration was associated with cardiac events. Only age-corrected QRS (rQRS) was associated with lethal and cardiac event-free survival from birth after correction for multiple testing.

conclusionVentricular myocardial conduction appears likely to play a role in the risk of arrhythmic events in patients with SCN5A-E1784K. This provides an important opportunity for the personalization of management and has the potential to guide preventative therapies.

Indexed as

Brugada SyndromeHeart Conduction SystemLong QT SyndromeNAV1.5 Voltage-Gated Sodium ChannelTachycardia, VentricularVentricular FibrillationAction PotentialsAdultDeath, Sudden, CardiacElectrocardiographyEuropeFemaleGenetic Predisposition to DiseaseHumansJapanMaleNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanBrugada syndromeECGLong QT syndromepenetrancePhenotype

Identifiers

PMID42114100
PMCPMC13237868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.